Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AN2 Therapeutics, Inc. ( (ANTX) ) has issued an update.
On March 19, 2026, AN2 Therapeutics’ board approved a repricing of all outstanding stock options granted under its 2017 and 2022 equity incentive plans, resetting the exercise price of eligible options, including those held by executives and directors, to $3.91 per share, the closing price of the company’s stock that day. Other terms of the options remain unchanged, and a “Premium End Date” structure requires holders who exercise or depart before the earlier of September 19, 2027, a change in control, or death or disability to pay the original exercise price, a design the board says balances retention incentives with limiting dilution and additional cash outlays.
The most recent analyst rating on (ANTX) stock is a Sell with a $3.50 price target. To see the full list of analyst forecasts on AN2 Therapeutics, Inc. stock, see the ANTX Stock Forecast page.
Spark’s Take on ANTX Stock
According to Spark, TipRanks’ AI Analyst, ANTX is a Neutral.
The score is held down primarily by weak financial performance (no revenue, ongoing losses, and negative free cash flow), only partly offset by a clean, low-debt balance sheet. Technicals are a positive with strong momentum above key moving averages, but the elevated RSI signals the move may be stretched. Valuation support is limited due to a negative P/E and no dividend yield provided.
To see Spark’s full report on ANTX stock, click here.
More about AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is a biopharmaceutical company, and its equity incentive structures indicate a focus on using stock-based compensation to attract, retain, and motivate employees, executives, and directors. The company utilizes equity incentive plans established in 2017 and 2022, reflecting a capital-markets-oriented approach to human capital management.
Average Trading Volume: 1,356,740
Technical Sentiment Signal: Buy
Current Market Cap: $140.5M
Learn more about ANTX stock on TipRanks’ Stock Analysis page.